December 15, 2011 |
In a trial involving nearly 40,000 women in the Netherlands, testing for the human papillomavirus, or HPV, allowed doctors to detect abnormal cervical cells earlier -- and prevent more cases of cervical cancer -- than administering pap smears alone. In the study, which was published Wednesday in the journal Lancet Oncology, a team of researchers led by Dr. Chris J.L.M. Meijer of the VU University Medical Centre in Amsterdam randomly assigned women ages 29-56 into two groups. The first group received an HPV test as well as a pap smear; the second group, a pap smear alone. Five years later, both groups had HPV tests and pap smears.
April 20, 2007 |
Sales of anti-cholesterol pills bolstered profits at Merck & Co. and Schering-Plough Corp., partners in marketing two of the fastest-growing treatments to prevent heart disease. Wyeth and Baxter International Inc. also reported Thursday an increase in first-quarter earnings on higher sales of drugs for arthritis and hemophilia. Wyeth shares fell after the fourth-largest U.S. drug maker said two new products would be delayed. Shares of Schering-Plough, based in Kenilworth, N.J., rose $2.45, or 8.
November 20, 2006
Q: I have human papilloma virus. Can I still get the shot that just came out — even though I already have the virus? VERENICE Carson City, Calif. A: The first vaccine to prevent human papilloma virus, called Gardasil, become available this year. The federal Advisory Committee on Immunization Practices voted in June to recommended the vaccine (a series of three shots given over a six-month period) for all girls and women ages 9 to 26. It's best if the vaccine is given before a female becomes sexually active.
August 18, 2006
LOS ANGELES MIDDLE SCHOOLERS will have the chance to benefit from an extraordinary medical breakthrough when they return to class in a few weeks: The L.A. Unified School District will make available to female students the first vaccine to protect against the sexually transmitted virus that causes cervical cancer. The vaccine, approved in June by the Food and Drug Administration, is most effective when given to girls before they become sexually active.
February 21, 2007 |
Merck & Co., bowing to pressure from parents and medical groups, is immediately suspending its lobbying campaign to persuade state legislatures to mandate that adolescent girls get the company's new vaccine against cervical cancer as a requirement for school attendance. The drug maker, which announced the change Tuesday, had been criticized for quietly funding the campaign, via a third party, to require that 11- and 12-year-old girls get the three-dose vaccine in order to attend school.
October 7, 2005 |
An experimental vaccine against cervical cancer has cleared its final clinical hurdle, showing in a large trial of more than 12,000 women that it is 100% effective in blocking the major forms of the disease, its manufacturer said Thursday. Merck Inc. said it would seek Food and Drug Administration approval for the vaccine, called Gardasil, this year and could begin marketing it next year. The vaccine immunizes against human papilloma virus, or HPV, the primary cause of cervical cancer.
October 23, 2008 |
Drug maker Merck & Co. said it would slash 7,200 jobs as part of a new restructuring program that comes as its third-quarter profit plunged 28% because of a hefty restructuring charge and flat sales. The maker of allergy and asthma treatment Singulair and cervical cancer vaccine Gardasil said it would cut nearly 13% of its workforce to lower overhead and become more competitive in its second major restructuring in less than three years. Merck shares closed down $1.96 at $28.01. Whitehouse Station, N.J.-based Merck took a $612-million charge for restructuring, reducing net income for its third quarter to $1.09 billion, or 51 cents a share.
June 19, 2013 |
The HPV vaccine may be controversial, but it works, new research shows. The rate of HPV infection among teenage girls dropped from 11.5% in the “pre-vaccine era” to 5.1% in the “vaccine era,” researchers from the Centers for Disease Control and Prevention reported Wednesday in the Journal of Infectious Diseases. That's a drop of 56%, the study notes. The infection rates cover the four types of HPV that are targeted by the vaccines Gardasil and Cervarix. Human papillomaviruses are the most common cause of sexually transmitted infections, and more than half of people who are sexually active become infected with one of the more than 40 types of HPV that are known to spread during vaginal, oral or anal sex, according to the National Cancer Institute . HPVs are responsible for nearly all cases of cervical cancer, along with most cases of anal cancer, the NCI says.
September 14, 2011
As GOP presidential candidates tussle over the latest issue to split the field — oddly enough, it's the rather obscure question of whether states should mandate vaccinating girls against a sexually transmitted virus — it's hard to tell which one ends up looking worst. But our vote goes to Minnesota Rep. Michele Bachmann, whose rumor-mongering rampage against a safe and effective vaccine could discourage parents from protecting their daughters against cancer. During Monday's debate, Bachmann and former Sen. Rick Santorum lashed out at Texas Gov. Rick Perry over his 2007 executive order that Texas schoolgirls had to be vaccinated against human papillomavirus (the order was later overturned by the state legislature)